Facebook
X
LinkedIn
Forward
Pharmacotherapy of Obesity in the Age of Incretin Analogs
Purpose
Mary Greeley Medical Center Grand Rounds is a multidisciplinary clinical activity that maintains, develops, or increases a physician's knowledge, skills, professional performance, and relationships to provide services for patients, the public, or the profession.
Target Audience
Physicians, advanced practice providers, nurses, medical students (rotating), non-medical students (rotating), and healthcare administrators.
Learning Objectives
- Discuss the concept of obesity management beyond body mass index.
- Recognize the general aspects and principles of pharmacotherapy of obesity.
- Review the utility of incretin-based anti-obesity medicines.
Speaker
Marcelo L. Correia, MD, MSc, PhD
Clinical Assistant Professor of Internal Medicine-Endocrinology and Metabolism, Division of Endocrinology, University of Iowa, Carver College of Medicine
- Medical School: State University of Rio de Janeiro, Rio de Janeiro, Brazil
- Residency in Internal Medicine: Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- Master's in Science in Medicine/Cardiology: State University of Rio de Janeiro, Rio de Janeiro, Brazil
- PhD in Translational Biomedicine: University of Iowa, Iowa City, Iowa
- Residency in Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa
- Fellowship in Endocrinology, University of Iowa Hospitals & Clinics, Iowa City, Iowa
Accreditation Statements
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
EDUCATIONAL GRANTS
No ineligible company provided financial support for this continuing education activity.
DISCLOSURES
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated through peer review by individuals with no relevant financial relationships or through attestation to evidence-based clinical guidelines.
- Marcelo L. Correia, MD, MSc, PhD - Speaker
- Consultant: Novo Nordisk
- Grants or Research Supports: Novartis, Novo Nordisk, Lilly, National Institute of Health, Patient-Centered Outcomes Research Institute, Stead Family Children's Hospital
- Clinical Trial Investigator: Novartis, Novo Nordisk, Lilly
CME Committee
- No Mary Greeley Medical Center CME Committee member who planned this activity has any financial relationship to disclose relating to the content.
Gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, and Availa Bank support this program. The content and selection of speaker(s) are the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee, not the sponsors of this program.
DISCLAIMER
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AOA Category 2A